Treatment and outcomes of large vessel arteritis

Frances A Borg1, Bhaskar Dasgupta

  • 1Department of Rheumatology, Southend University Hospital, Essex, UK.

Insights

Giant cell arteritis (GCA) and Takayasu's arteritis (TA) are inflammatory diseases affecting large arteries. Early recognition and treatment are crucial to prevent vision loss and other complications.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) and Takayasu's arteritis (TA) are systemic inflammatory conditions affecting large arteries.
  • These conditions can lead to critical ischemia and significant morbidity, including permanent vision loss in GCA.
  • Delayed diagnosis, often due to non-specific early symptoms and discordant inflammatory markers, complicates management.

Purpose of the Study:

  • To review the current understanding and management of large vessel vasculitis, focusing on GCA and TA.
  • To highlight the challenges in early diagnosis and the role of modern imaging techniques.
  • To discuss current and potential future therapeutic strategies.

Main Methods:

  • Literature review of large vessel vasculitis, focusing on diagnosis and treatment.
  • Analysis of clinical presentation, diagnostic challenges, and therapeutic outcomes.
  • Evaluation of the role of imaging and novel therapies.

Main Results:

  • GCA is a medical emergency with high risk of early neuro-ophthalmic complications, including vision loss.
  • Diagnosis of large vessel vasculitis is frequently delayed.
  • Corticosteroids remain the primary treatment, with mixed results for conventional DMARDs and ongoing evaluation of biologics.

Conclusions:

  • Prompt recognition and treatment of GCA are essential to prevent irreversible vision loss.
  • Improved diagnostic strategies, including advanced imaging, are needed.
  • Further research into steroid-sparing therapies, including biologics, is required for effective long-term management of large vessel vasculitis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...